WASHINGTON (Legal Newsline) — The Federal Trade Commission
(FTC) announced Dec. 13 that, following a public comment period, it has approved a
final consent order against Mars Petcare U.S. settling charges of false
advertising related to the health benefits of the company’s
Eukanuba brand dog food.
The FTC filed the complaint in August, charging that in
advertisements, the defendant marketed a 10-year study showing that dogs fed
Eukanuba could extend their expected lifespan by 30 percent or more. The FTC
argued the claims were false or unsubstantiated, in violation of the FTC
As per the terms of the settlement agreement, Mars Petcare
cannot misrepresent the existence, results, conclusions or interpretations of
any study in the future. Additionally, it cannot falsely state that the health
benefits claimed are scientifically proven. The settlement agreement contains
requirements for compliance and monitoring, so as to ensure the company abides
by the agreement’s terms.
The FTC voted 3-0 to approve the final order and responses
to the public commenters. David M. Newman of the FTC Western Region is the
staff contact for the case.